Premium Reports
Contact KLAS
 Download Report    Zoom in charts

Preferences

   Bookmark

Related Series

 No Related Series

 End chart zoom
Infectious Disease Connect Infectious Disease Connect
* A page refresh may be necessary to see the updated image

Infectious Disease Connect
Emerging Technology Spotlight 2020

author - Joshua Jensen
Author
Joshua Jensen
author - Sam Eaquinto
Author
Sam Eaquinto
 
December 18, 2020

Current Time Inside Cache Tag Helper: 12/6/2022 6:40:19 AM and Model.reportId = 1853

Infectious Disease Connect (ID Connect) provides telemedicine access to infectious disease specialists when they are needed. ID Connect’s software, ILÚM Insight, is an infectious disease decision support platform that identifies real-time opportunities to intervene in patient cases to arrive at the optimal therapy and antibiotic utilization. Together, IDConnect’s software and services provide comprehensive consultations and assessments. This spotlight will examine the experience of early adopters.

to see the full dataset.

if you don't have a login, getting started is easy.

Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.
Current Time Inside Cache Tag Helper: 12/6/2022 6:40:19 AM and Model.reportId = 1853

Key Findings

  1. ID Connect Customer Experience: An Initial Look
  2. Customer-Validated Features & Services
  3. ID Connect: Company Profile at a Glance
  4. ID Connect: Healthcare Executive Interview
  5. KLAS' Points to Ponder
author - Madison Moniz
Designer
Madison Moniz
author - Joshua Jensen
Project Manager
Joshua Jensen
 Download Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2022 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.